During the past decade, Anticancer Hospital Ag Savas; 1St Dept of Internal Medicine conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 6 clinical trials were completed, i.e. on average, 20.7% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 5 clinical trials were completed. i.e. 35.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Anticancer Hospital Ag Savas; 1St Dept of Internal Medicine" #1 sponsor was "Hoffmann-La Roche" with 15 trials, followed by "Saint Savvas Anticancer Hospital" with 5 trials sponsored, "European Lung Cancer Working Party" with 4 trials sponsored, "Hellenic Cooperative Oncology Group" with 4 trials sponsored and "Eli Lilly and Company" with 4 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Anticancer Hospital Ag Savas; 1St Dept of Internal Medicine" #1 collaborator was "Sanofi" with 3 trials as a collaborator, "University of Thessaly" with 2 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Anticancer Hospital Ag Savas; 1St Dept of Internal Medicine" are "Breast Cancer" (5 trials), "Breast Neoplasms" (4 trials), "Carcinoma, Non-Small-Cell Lung" (4 trials), "Blood Protein Disorders" (2 trials) and "Hematologic Diseases" (2 trials). Many other conditions were trialed in "Anticancer Hospital Ag Savas; 1St Dept of Internal Medicine" in a lesser frequency.

Most popular intervention types in "Anticancer Hospital Ag Savas; 1St Dept of Internal Medicine" are "Drug" (36 trials), "Other" (3 trials), "Diagnostic Test" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (8 trials), "Placebo" (7 trials), "Paclitaxel" (4 trials), "Docetaxel" (3 trials) and "Fulvestrant" (3 trials). Other intervention names were less common.

The vast majority of trials in "Anticancer Hospital Ag Savas; 1St Dept of Internal Medicine" are 36 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Anticancer Hospital Ag Savas; 1St Dept of Internal Medicine". 2 are not yet recruiting, 8 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Anticancer Hospital Ag Savas; 1St Dept of Internal Medicine, 1 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Anticancer Hospital Ag Savas; 1St Dept of Internal Medicine, 0 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".

Anticancer Hospital Ag Savas; 1St Dept of Internal Medicine has several departments that took part in Clinical trials: "Children's Hospital Agia Sophia, National and Kapodistrian University of Athens Medical School" - 2 trials